Literature DB >> 15726276

HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT.

B Sporer, R Linke, K Seelos, R Paul, T Klopstock, H-W Pfister.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15726276     DOI： 10.1007/s00415-005-0626-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  13 in total

1.  Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients.

Authors:  A di Rocco; T Bottiglieri; D Dorfman; P Werner; C Morrison; D Simpson
Journal:  Clin Neuropharmacol       Date:  2000 Jul-Aug       Impact factor: 1.592

2.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

3.  Chorea in patients with AIDS.

Authors:  I Piccolo; R Causarano; R Sterzi; M Sberna; P L Oreste; C Moioli; L Caggese; F Girotti
Journal:  Acta Neurol Scand       Date:  1999-11       Impact factor: 3.209

4.  HIV encephalitis presenting with severe generalized chorea.

Authors:  B V Gallo; L M Shulman; W J Weiner; C K Petito; J R Berger
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1.

Authors:  H J von Giesen; H J Wittsack; F Wenserski; H Köller; H Hefter; G Arendt
Journal:  Arch Neurol       Date:  2001-08

6.  The AIDS dementia complex: II. Neuropathology.

Authors:  B A Navia; E S Cho; C K Petito; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

7.  Cerebrovascular changes in the basal ganglia with HIV dementia.

Authors:  J R Berger; A Nath; R N Greenberg; A H Andersen; R A Greene; A Bognar; M J Avison
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

8.  Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report.

Authors:  S A Factor; G D Podskalny; K D Barron
Journal:  J Neurol Sci       Date:  1994-12-01       Impact factor: 3.181

9.  [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].

Authors:  H B Saur; P Bartenstein; O Schober; C Oberwittler; H Lerch; H Masur
Journal:  Nuklearmedizin       Date:  1994-10       Impact factor: 1.379

10.  Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging.

Authors:  E H Aylward; J D Henderer; J C McArthur; P D Brettschneider; G J Harris; P E Barta; G D Pearlson
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910
View more
  11 in total

1.  Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons.

Authors:  I N Singh; N El-Hage; M E Campbell; S E Lutz; P E Knapp; A Nath; K F Hauser
Journal:  Neuroscience       Date:  2005-08-19       Impact factor: 3.590

2.  Reliability and validity of MRI-based automated volumetry software relative to auto-assisted manual measurement of subcortical structures in HIV-infected patients from a multisite study.

Authors:  Jeffrey Dewey; George Hana; Troy Russell; Jared Price; Daniel McCaffrey; Jaroslaw Harezlak; Ekta Sem; Joy C Anyanwu; Charles R Guttmann; Bradford Navia; Ronald Cohen; David F Tate
Journal:  Neuroimage       Date:  2010-03-22       Impact factor: 6.556

Review 3.  Diagnosis and treatment of chorea syndromes.

Authors:  Andreas Hermann; Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 4.  Differential diagnosis of chorea.

Authors:  Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

5.  Conditional Tat protein brain expression in the GT-tg bigenic mouse induces cerebral fractional anisotropy abnormalities.

Authors:  Amanda N Carey; Xiaoxu Liu; Dionyssios Mintzopoulos; Jason J Paris; Jay P McLaughlin; Marc J Kaufman
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 6.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

7.  The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Authors:  M J Ferris; D Frederick-Duus; J Fadel; C F Mactutus; R M Booze
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

8.  No evidence of perfusion abnormalities in the basal ganglia of a patient with generalized chorea-ballism and polycythaemia vera: analysis using subtraction SPECT co-registered to MRI.

Authors:  Woojun Kim; Joong-Seok Kim; Kwang-Soo Lee; Yeong-In Kim; Chong-Won Park; Yong-An Chung
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

Review 9.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

Review 10.  The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.

Authors:  Sonia Mediouni; Maria Cecilia Garibaldi Marcondes; Courtney Miller; Jay P McLaughlin; Susana T Valente
Journal:  Front Microbiol       Date:  2015-10-23       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.